首页> 外文期刊>Modern Pathology >Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
【24h】

Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression

机译:分化的发育不良的掺入改善了恶性进展的增加风险下的口腔白斑预测

获取原文
           

摘要

Oral leukoplakia is the most common oral potentially malignant disorder with a malignant transformation rate into oral squamous cell carcinoma of 1-3% annually. The presence and grade of World Health Organization defined dysplasia is an important histological marker to assess the risk for malignant transformation, but is not sufficiently accurate to personalize treatment and surveillance. Differentiated dysplasia, known from differentiated vulvar intraepithelial neoplasia, is hitherto not used in oral dysplasia grading. We hypothesized that assessing differentiated dysplasia besides World Health Organization defined (classic) dysplasia will improve risk assessment of malignant transformation of oral leukoplakia. We investigated a retrospective cohort consisting of 84 oral leukoplakia patients. Biopsies were assessed for dysplasia presence and grade, and the expression of keratins 13 (CK13) and 17, known to be dysregulated in dysplastic vulvar mucosa. In dysplastic oral lesions, differentiated dysplasia is as common as classic dysplasia. In 25 out of 84 (30%) patients, squamous cell carcinoma of the upper aerodigestive tract developed during follow-up. Considering only classic dysplasia, 11 out of 56 (20%) patients with nondysplastic lesions progressed. With the incorporation of differentiated dysplasia, only 2 out of 30 (7%) patients with nondysplastic lesions progressed. The risk of progression increased from 3.26 (Hazard ratio, p-=-0.002) when only classic dysplasia is considered to 7.43 (Hazard ratio, p-=-0.001) when classic and differentiated dysplasia are combined. Loss of CK13, combined with presence of dysplasia, is associated with greater risk of malignant progression (p-=-0.006). This study demonstrates that differentiated dysplasia should be recognized as a separate type of dysplasia in the oral mucosa and that its distinction from classic dysplasia is of pathological and clinical significance since it is a strong (co)prognostic histopathological marker for oral malignant transformation. In oral lesions without dysplasia and retained CK13 staining the risk for progression is very low.
机译:口腔白斑是最常见的口腔潜在恶性疾病,恶性转化率为每年1-3%的口腔鳞状细胞癌。世界卫生组织的存在和等级定义的发育不良是一种重要的组织学标志,以评估恶性转化的风险,但对个性化治疗和监督没有足够的准确性。迄今为止,来自差异化外阴上皮内瘤周期的差异化发育性是不用于口腔发育不良的分级。我们假设除了定义的世界卫生组织(经典)发育不良而评估分化的发育不良,将改善口腔白斑恶性转化的风险评估。我们调查了由84名口服白斑患者组成的回顾性群体。评估活组织检查对于发育不良的存在和等级,并且特角蛋白酶13(CK13)和17的表达,已知在发育外部外阴粘膜中的缺乏测定。在发狂的口腔病变中,分化的发育不良与经典发育不良一样常见。在84名(30%)的患者中,在后续行动期间开发的上部机场的鳞状细胞癌。仅考虑患有抗性病变的56名(20%)患者的经典发育不良,11例进展。随着分化的发育不良的掺入,只有30名(7%)患者的鼻塑性病变的患者只有2例进展。当同时认为经典和分化的发育性相结合时,进展的进展危险从3.26(危险比,p - = -002)增加到7.43(危险比,p - = - 0.001)。 CK13的丧失与发育不良的存在相结合,与更大的恶性进展风险有关(p - = - 0.006)。该研究表明,分化的发育不良应该被认为是口腔粘膜中的单独类型的发育不良,并且其与经典发育不良的区别是病理和临床意义,因为它是口服恶性转化的强(CO)预后组分病理学标志物。在没有发育不良的口腔病变中,保留CK13染色进展的风险非常低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号